Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding receipt of communication from Joint Commissioner (Drug), Food and Drug Administration, Maharashtra State, Nagpur Division.
This is in continuation of our earlier letter dated May 30, 2026 please find enclosed Transcript of Earning Conference Call Q4FY26.
Additional Details for Corporate Announcement filed under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
News paper publication of Audited financial results of the Company for quarter and year ended on March 31, 2026.
Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding receipt of Show Cause Notice from Deputy Commissioner (S.I.B./Enforcement), State Tax Department, Uttarakhand, Roshanabad, Haridwar.
Audio recording of the Earning Conference Call held with investors on May 30, 2026
Audited Financial Results for Quarter and Year Ended 31.03.2026
In terms of Regulation 30 and 33 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) as amended, we wish to inform you that the Board of Directors at their meeting held on today i.e. Saturday, May 30, 2026, has inter alia, considered and approved the audited (standalone & consolidated) financial results for the quarter and year ended March 31, 2026, duly reviewed by the Audit Committee. The audited (standalone & consolidated) financial results of the Company for the quarter and year ended March 31, 2026 and Audit Report issued by the Statutory Auditors are enclosed herewith.
Further to our letter dated May 27, 2025, please find enclosed clarification on disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding Show Cause Notice issued by Assistant Commissioner (ST), Royapuram (C) Assessment Circle, North Division, Chennai.
Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Annual Secretarial Compliance Report of Patanjali Foods Limited for the financial year ended March 31, 2026 issued by P. Diwan & Associates, Practicing Company Secretaries.
| Particulars | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 7,173.06 | 8,154.19 | 9,103.13 | 9,692.21 | 8,899.71 | 9,798.84 | 10,483.71 | 11,155.60 |
| YOY Revenue Growth % | - | - | - | - | 24.07% | 20.17% | 15.17% | 15.1% |
| Other Income | 29.30 | 44.34 | 40.65 | 52.53 | 12.99 | 51.23 | 57.41 | 56.57 |
| Total Income | 7,202.36 | 8,198.53 | 9,143.78 | 9,744.74 | 8,912.70 | 9,850.07 | 10,541.12 | 11,212.17 |
| Total Expenses + | 6,843.38 | 7,781.64 | 8,652.59 | 9,286.27 | 8,664.13 | 9,344.98 | 10,146.70 | 10,807.71 |
| Cost of Materials Consumed | 4,290.11 | 4,703.55 | 5,981.50 | 6,122.58 | 6,139.09 | 6,716.42 | 7,097.87 | 7,884.44 |
| Employee Benefit Expense | 117.28 | 130.11 | 144.06 | 161.29 | 148.51 | 148.49 | 176.40 | 164.79 |
| Other Expenses | 464.84 | 669.23 | 756.76 | 926.24 | 776.54 | 750.84 | 753.17 | 731.84 |
| Operating Profit | 329.68 | 372.55 | 450.55 | 405.94 | 235.57 | 453.86 | 337.01 | 347.89 |
| OPM % | 4.6% | 4.6% | 4.9% | 4.2% | 2.6% | 4.6% | 3.2% | 3.1% |
| Profit Before Tax + | 358.98 | 416.89 | 491.20 | 458.47 | 248.57 | 505.09 | 364.23 | 235.65 |
| Tax Expense | 96.25 | 108.31 | 120.32 | 99.95 | 68.21 | -11.60 | -229.21 | -288.33 |
| Tax % | 26.8% | 26% | 24.5% | 21.8% | 27.4% | -2.3% | -62.9% | -122.4% |
| Profit After Tax | 262.72 | 308.58 | 370.88 | 358.52 | 180.36 | 516.70 | 593.44 | 523.98 |
| EPS (Basic) | 7.26 | 8.53 | 10.24 | 9.91 | 4.98 | 4.75 | 5.46 | 4.82 |
| Particulars | Mar 2026 | Mar 2025 |
|---|---|---|
| Revenue from Operations | 40,169.58 | 34,156.97 |
| YOY Revenue Growth % | 17.6% | - |
| Other Income | 178.20 | 132.43 |
| Total Income | 40,347.78 | 34,289.40 |
| Total Expenses + | 38,795.24 | 32,563.87 |
| Cost of Materials Consumed | 27,837.82 | 21,097.74 |
| Employee Benefit Expense | 638.19 | 552.74 |
| Other Expenses | 2,844.12 | 2,817.06 |
| Operating Profit | 1,374.34 | 1,593.10 |
| OPM % | 3.4% | 4.7% |
| Profit Before Exceptional | 1,552.54 | 1,725.53 |
| Exceptional Items | -199.00 | 0.00 |
| Profit Before Tax + | 1,353.54 | 1,725.53 |
| Tax Expense | -460.94 | 424.82 |
| Tax % | -34.1% | 24.6% |
| Profit After Tax | 1,814.47 | 1,300.71 |
| EPS (Basic) | 16.68 | 35.94 |
| Particulars | Mar 2026 | Mar 2025 |
|---|---|---|
| ASSETS | ||
| Non-Current Assets + | 6,696.91 | 6,113.85 |
| Property, Plant & Equipment | 3,818.51 | 3,990.52 |
| Capital Work in Progress | 50.70 | 93.45 |
| Non-Current Investments | 13.65 | 20.62 |
| Goodwill | 10.82 | 10.82 |
| Other Intangible Assets | 1,536.76 | 1,551.66 |
| Current Assets + | 12,092.63 | 9,399.37 |
| Inventories | 7,281.59 | 6,210.29 |
| Trade Receivables | 2,406.93 | 1,584.68 |
| Cash and Cash Equivalents | 616.30 | 109.16 |
| Current Investments | 10.84 | 137.72 |
| LIABILITIES & EQUITY | ||
| Total Equity | 13,096.12 | 11,370.89 |
| Equity Share Capital | 217.58 | 72.42 |
| Other Equity | 12,878.54 | 11,298.47 |
| Non-Current Liabilities | 56.79 | 40.78 |
| Current Liabilities | 5,645.10 | 4,103.78 |
| Total Liabilities | 5,706.21 | 4,146.29 |
| Particulars | Mar 2026 | Mar 2025 |
|---|---|---|
| Cash from Operating Activities | -332.63 | 298.62 |
| Cash from Investing Activities | -840.27 | -115.62 |
| Cash from Financing Activities | 1,680.04 | -611.27 |
| Net Increase/Decrease in Cash | 507.14 | -428.27 |